Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations
Elevated serum uric acid levels cause gout and are a risk factor for cardiovascular disease and diabetes. To investigate the polygenetic basis of serum uric acid levels, we conducted a meta-analysis of genome-wide association scans from 14 studies totalling 28,141 participants of European descent, resulting in identification of 954 SNPs distributed across nine loci that exceeded the threshold of genome-wide significance, five of which are novel. Overall, the common variants associated with serum uric acid levels fall in the following nine regions: SLC2A9 (p = 5.2×10−201), ABCG2 (p = 3.1×10−26), SLC17A1 (p = 3.0×10−14), SLC22A11 (p = 6.7×10−14), SLC22A12 (p = 2.0×10−9), SLC16A9 (p = 1.1×10−8), GCKR (p = 1.4×10−9), LRRC16A (p = 8.5×10−9), and near PDZK1 (p = 2.7×10−9). Identified variants were analyzed for gender differences. We found that the minor allele for rs734553 in SLC2A9 has greater influence in lowering uric acid levels in women and the minor allele of rs2231142 in ABCG2 elevates uric acid levels more strongly in men compared to women. To further characterize the identified variants, we analyzed their association with a panel of metabolites. rs12356193 within SLC16A9 was associated with DL-carnitine (p = 4.0×10−26) and propionyl-L-carnitine (p = 5.0×10−8) concentrations, which in turn were associated with serum UA levels (p = 1.4×10−57 and p = 8.1×10−54, respectively), forming a triangle between SNP, metabolites, and UA levels. Taken together, these associations highlight additional pathways that are important in the regulation of serum uric acid levels and point toward novel potential targets for pharmacological intervention to prevent or treat hyperuricemia. In addition, these findings strongly support the hypothesis that transport proteins are key in regulating serum uric acid levels.
Vyšlo v časopise:
Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations. PLoS Genet 5(6): e32767. doi:10.1371/journal.pgen.1000504
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1000504
Souhrn
Elevated serum uric acid levels cause gout and are a risk factor for cardiovascular disease and diabetes. To investigate the polygenetic basis of serum uric acid levels, we conducted a meta-analysis of genome-wide association scans from 14 studies totalling 28,141 participants of European descent, resulting in identification of 954 SNPs distributed across nine loci that exceeded the threshold of genome-wide significance, five of which are novel. Overall, the common variants associated with serum uric acid levels fall in the following nine regions: SLC2A9 (p = 5.2×10−201), ABCG2 (p = 3.1×10−26), SLC17A1 (p = 3.0×10−14), SLC22A11 (p = 6.7×10−14), SLC22A12 (p = 2.0×10−9), SLC16A9 (p = 1.1×10−8), GCKR (p = 1.4×10−9), LRRC16A (p = 8.5×10−9), and near PDZK1 (p = 2.7×10−9). Identified variants were analyzed for gender differences. We found that the minor allele for rs734553 in SLC2A9 has greater influence in lowering uric acid levels in women and the minor allele of rs2231142 in ABCG2 elevates uric acid levels more strongly in men compared to women. To further characterize the identified variants, we analyzed their association with a panel of metabolites. rs12356193 within SLC16A9 was associated with DL-carnitine (p = 4.0×10−26) and propionyl-L-carnitine (p = 5.0×10−8) concentrations, which in turn were associated with serum UA levels (p = 1.4×10−57 and p = 8.1×10−54, respectively), forming a triangle between SNP, metabolites, and UA levels. Taken together, these associations highlight additional pathways that are important in the regulation of serum uric acid levels and point toward novel potential targets for pharmacological intervention to prevent or treat hyperuricemia. In addition, these findings strongly support the hypothesis that transport proteins are key in regulating serum uric acid levels.
Zdroje
1. TaniguchiA
KamataniN
2008 Control of renal uric acid excretion and gout. Curr Opin Rheumatol 20 192 197
2. KoenigW
MeisingerC
2008 Uric acid, type 2 diabetes, and cardiovascular diseases: fueling the common soil hypothesis? Clin Chem 54 231 233
3. HaydenMR
TyagiSC
2004 Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond) 1 10
4. CutlerRG
1984 Urate and ascorbate: their possible roles as antioxidants in determining longevity of mammalian species. Arch Gerontol Geriatr 3 321 348
5. WhitfieldJB
MartinNG
1983 Inheritance and alcohol as factors influencing plasma uric acid levels. Acta Genet Med Gemellol (Roma ) 32 117 126
6. DoringA
GiegerC
MehtaD
GohlkeH
ProkischH
2008 SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 40 430 436
7. LiS
SannaS
MaschioA
BusoneroF
UsalaG
2007 The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 3 e194 doi:10.1371/journal.pgen.0030194
8. VitartV
RudanI
HaywardC
GrayNK
FloydJ
2008 SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 40 437 442
9. WallaceC
NewhouseSJ
BraundP
ZhangF
TobinM
2008 Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 82 139 149
10. CaulfieldMJ
MunroePB
O'NeillD
WitkowskaK
CharcharFJ
2008 SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 5 e197 doi:10.1371/journal.pmed.0050197
11. DehghanA
KottgenA
YangQ
HwangSJ
KaoWL
2008 Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372 1953 1961
12. SparsoT
AndersenG
NielsenT
BurgdorfKS
GjesingAP
2008 The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia 51 70 75
13. AnzaiN
MiyazakiH
NoshiroR
KhamdangS
ChairoungduaA
2004 The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J Biol Chem 279 45942 45950
14. HalestrapAP
PriceNT
1999 The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 343 Pt 2 281 299
15. HalestrapAP
MeredithD
2004 The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 447 619 628
16. SaxenaR
VoightBF
LyssenkoV
BurttNP
de BakkerPI
2007 Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 1331 1336
17. VaxillaireM
Cavalcanti-ProencaC
DechaumeA
TichetJ
MarreM
2008 The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes 57 2253 2257
18. Orho-MelanderM
MelanderO
GuiducciC
Perez-MartinezP
CorellaD
2008 Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes 57 3112 3121
19. Ter MaatenJC
VoorburgA
HeineRJ
Ter WeePM
DonkerAJ
1997 Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond) 92 51 58
20. FacchiniF
ChenYD
HollenbeckCB
ReavenGM
1991 Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266 3008 3011
21. ChoiHK
MountDB
ReginatoAM
2005 Pathogenesis of gout. Ann Intern Med 143 499 516
22. BakkerSJ
GansRO
Ter MaatenJC
TeerlinkT
WesterhoffHV
2001 The potential role of adenosine in the pathophysiology of the insulin resistance syndrome. Atherosclerosis 155 283 290
23. YangC
PringM
WearMA
HuangM
CooperJA
2005 Mammalian CARMIL inhibits actin filament capping by capping protein. Dev Cell 9 209 221
24. SkovhusKV
BergholdtR
ErichsenC
SparreT
NerupJ
2006 Identification and characterization of secretagogin promoter activity. Scand J Immunol 64 639 645
25. EnomotoA
KimuraH
ChairoungduaA
ShigetaY
JutabhaP
2002 Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417 447 452
26. AnzaiN
EnomotoA
EndouH
2005 Renal urate handling: clinical relevance of recent advances. Curr Rheumatol Rep 7 227 234
27. EkaratanawongS
AnzaiN
JutabhaP
MiyazakiH
NoshiroR
2004 Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci 94 297 304
28. AnzaiN
KanaiY
EndouH
2007 New insights into renal transport of urate. Curr Opin Rheumatol 19 151 157
29. GiegerC
GeistlingerL
AltmaierE
HrabedA
KronenbergF
2008 Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 4 e1000282 doi:10.1371/journal.pgen.1000282
30. NozakiS
TanakaM
MizunoK
AtakaS
MizumaH
2009 Mental and physical fatigue-related biochemical alterations. Nutrition 25 51 57
31. NakazonoK
WatanabeN
MatsunoK
SasakiJ
SatoT
1991 Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A 88 10045 10048
32. RauchovaH
DobesovaZ
DrahotaZ
ZichaJ
KunesJ
1998 The effect of chronic L-carnitine treatment on blood pressure and plasma lipids in spontaneously hypertensive rats. Eur J Pharmacol 342 235 239
33. HuangW
ShaikhSN
GanapathyME
HopferU
LeibachFH
1999 Carnitine transport and its inhibition by sulfonylureas in human kidney proximal tubular epithelial cells. Biochem Pharmacol 58 1361 1370
34. RoschingerW
MuntauAC
DuranM
DorlandL
IJlstL
2000 Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle. Clin Chim Acta 298 55 68
35. LootsDT
MienieLJ
BerghJJ
Van der SchyfCJ
2004 Acetyl-L-carnitine prevents total body hydroxyl free radical and uric acid production induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the rat. Life Sci 75 1243 1253
36. StapletonSR
CurrieKP
ScottRH
BellBA
1992 Palmitoyl-DL-carnitine has calcium-dependent effects on cultured neurones from rat dorsal root ganglia. Br J Pharmacol 107 1192 1197
37. FredrikssonR
NordstromKJ
StephanssonO
HagglundMG
SchiothHB
2008 The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families. FEBS Lett 582 3811 3816
38. LiY
AbecasisGR
2006 Mach 1.0: rapid haplotype reconstruction and missing genotype inference. Am J Hum Genet S79 2290
39. MarchiniJ
HowieB
MyersS
McVeanG
DonnellyP
2007 A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39 906 913
40. BacanuSA
DevlinB
RoederK
2000 The power of genomic control. Am J Hum Genet 66 1933 1944
41. DudbridgeF
GusnantoA
2008 Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 32 227 234
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2009 Číslo 6
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Cytoplasmic Streaming in : Disperse the Plug To Increase the Flow?
- Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations
- Is a Novel Locus for Waist Circumference: A Genome-Wide Association Study from the CHARGE Consortium
- Asymmetric Strand Segregation: Epigenetic Costs of Genetic Fidelity?